Prism Medico

{
  "main_header": {
    "sid": 701766,
    "name": "Prism Medico",
    "stock_name": "Prism Medico",
    "full_name": "Prism Medico & Pharmacy Ltd",
    "name_url": "stocks-analysis/prism-medico",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "16.99",
    "chg": -0.11,
    "chgp": "-0.64%",
    "dir": -1,
    "prev_price": "17.10",
    "mcapval": "11.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 512217,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE730E01016",
    "curr_date": "Feb 13",
    "curr_time": "",
    "bse_nse_vol": "7.81 k",
    "exc_status": "Active",
    "traded_date": "Feb 13, 2026",
    "traded_date_str": "2026 02 13",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/prism-medico-701766-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Prism Medico & Pharmacy Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-prism-medico-pharmacy-ltd-fallingrising-3779289",
        "imagepath": "",
        "date": "2026-01-03 01:45:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>On 02-Jan, Prism Medico &amp; Pharmacy Ltd’s shares declined by nearly 5%, underperforming its sector by 5.32%. This drop is consistent with the stock’s broader trend of lagging behind the benchmark indices. Over the past week, the stock has fallen by 7.87%, while the Sensex gained 0.85%. Year-to-date, the stock is down 4.47%, contrasting with the Sensex’s modest 0.64% rise. The disparity is even more pronounced over longer periods, with the stock delivering a negative 22.57% return over the last year, compared to the Sensex’s positive 7.28%. Over three and five years, the stock has declined by 45.08% and 28.96% respectively, while the Sensex has surged by 40.21% and 79.16% in the same periods.</p>\n<p><strong>Technical Indicators an..."
      },
      {
        "title": "Prism Medico & Pharmacy Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/prism-medico-pharmacy-ltd-is-rated-sell-3771502",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PrismMedicoPhar_mojoScore_3771502.png",
        "date": "2025-12-26 21:51:26",
        "description": "Prism Medico &amp; Pharmacy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 26 December 2025, providing investors with an up-to-date view of the company's fundamentals, returns, and technical outlook."
      },
      {
        "title": "Prism Medico’s Evaluation Revised Amidst Weak Fundamentals and Market Underperformance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/prism-medico-downgraded-to-sell-by-marketsmojo-amid-weak-fundamentals-3755251",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PrismMedico_mojoScore_3755251.png",
        "date": "2025-12-10 10:10:07",
        "description": "Prism Medico, a microcap player in the Non Banking Financial Company (NBFC) sector, has experienced a revision in its market assessment reflecting challenges in its financial health and stock performance. Recent analytical changes highlight concerns over the company’s operational results and market returns, signalling a cautious outlook for investors."
      },
      {
        "title": "Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3746826",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PrismMedicoPhar_only_sellers_3746826.png",
        "date": "2025-12-04 13:25:40",
        "description": "Prism Medico & Pharmacy Ltd is currently experiencing significant selling pressure, with the stock registering only sell orders and no buyers in the queue. This extreme market behaviour signals distress selling, as the company’s shares continue to face downward momentum amid a series of consecutive losses."
      },
      {
        "title": "Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3744351",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PrismMedicoPhar_only_sellers_3744351.png",
        "date": "2025-12-03 13:45:24",
        "description": "Prism Medico & Pharmacy Ltd has encountered significant selling pressure, with the stock registering a sharp decline and exhibiting a complete absence of buyers on the trading day. This distress selling signals heightened market caution surrounding the company’s near-term prospects."
      },
      {
        "title": "Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3737823",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PrismMedicoPhar_only_sellers_3737823.png",
        "date": "2025-12-01 09:50:25",
        "description": "Prism Medico & Pharmacy Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.96% today and exhibiting no buying interest. This distress selling comes amid a series of consecutive losses, signalling heightened investor caution in the Non Banking Financial Company (NBFC) sector."
      },
      {
        "title": "Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3728113",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PrismMedicoPhar_only_sellers_3728113.png",
        "date": "2025-11-25 09:40:58",
        "description": "Prism Medico & Pharmacy Ltd is currently experiencing significant selling pressure, with the stock registering only sell orders and no buyers in the queue. This distress selling has resulted in a continuation of losses, reflecting a challenging phase for the company within the Non Banking Financial Company (NBFC) sector."
      },
      {
        "title": "Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3725370",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PrismMedicoPhar_only_sellers_3725370.png",
        "date": "2025-11-24 11:30:41",
        "description": "Prism Medico & Pharmacy Ltd is experiencing severe selling pressure, with the stock registering a lower circuit and an absence of buyers on the trading day. The company’s shares have recorded consecutive losses across multiple time frames, signalling distress selling and a challenging market environment for this Non Banking Financial Company (NBFC)."
      },
      {
        "title": "Is Prism Medico overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-prism-medico-overvalued-or-undervalued-3713567",
        "imagepath": "",
        "date": "2025-11-19 08:08:21",
        "description": "As of 18 November 2025, the valuation grade for Prism Medico has moved from very attractive to fair. Based on the current analysis, the company appears to be fairly valued. The key ratios include a PE ratio of 19.52, an EV to EBITDA of 11.84, and a Price to Book Value of 0.79. \n\nIn comparison to its peers, Prism Medico's valuation is significantly lower than that of Max Healthcare, which has a PE ratio of 77.03, and Apollo Hospitals, with a PE ratio of 63.51. Despite the fair valuation, Prism Medico has underperformed the Sensex over the past year, with a stock return of -24.32% compared to the Sensex's return of 9.48%...."
      }
    ],
    "total": 159,
    "sid": "701766",
    "stock_news_url": "https://www.marketsmojo.com/news/prism-medico-pharmacy-701766"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Consideration Approval And Taking On Record The Unaudited Standalone Financial Results Of The Company Along With The Limited Review Report For The Quarter Ended 31St December 2025.",
      "datetime": "07-Feb-2026",
      "details": "Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve the Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter ended 31st December 2025 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Undertaking Of Functional Website",
      "datetime": "30-Jan-2026",
      "details": "Please find the attached Disclosure and Kindly take the same on record.",
      "source": "BSE"
    },
    {
      "caption": "Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.",
      "datetime": "16-Jan-2026",
      "details": "Dear Sir/Madam Pursuant to Regulation 13(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 please find attached the certificate issued by RTA. Thanking You.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Prism Medico & Pharmacy Ltd falling/rising?

2026-01-03 01:45:08

Recent Price Movement and Market Comparison

On 02-Jan, Prism Medico & Pharmacy Ltd’s shares declined by nearly 5%, underperforming its sector by 5.32%. This drop is consistent with the stock’s broader trend of lagging behind the benchmark indices. Over the past week, the stock has fallen by 7.87%, while the Sensex gained 0.85%. Year-to-date, the stock is down 4.47%, contrasting with the Sensex’s modest 0.64% rise. The disparity is even more pronounced over longer periods, with the stock delivering a negative 22.57% return over the last year, compared to the Sensex’s positive 7.28%. Over three and five years, the stock has declined by 45.08% and 28.96% respectively, while the Sensex has surged by 40.21% and 79.16% in the same periods.

Technical Indicators an...

Read full news article

Prism Medico & Pharmacy Ltd is Rated Sell

2025-12-26 21:51:26

Prism Medico & Pharmacy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 26 December 2025, providing investors with an up-to-date view of the company's fundamentals, returns, and technical outlook.

Read full news article

Prism Medico’s Evaluation Revised Amidst Weak Fundamentals and Market Underperformance

2025-12-10 10:10:07

Prism Medico, a microcap player in the Non Banking Financial Company (NBFC) sector, has experienced a revision in its market assessment reflecting challenges in its financial health and stock performance. Recent analytical changes highlight concerns over the company’s operational results and market returns, signalling a cautious outlook for investors.

Read full news article

Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-04 13:25:40

Prism Medico & Pharmacy Ltd is currently experiencing significant selling pressure, with the stock registering only sell orders and no buyers in the queue. This extreme market behaviour signals distress selling, as the company’s shares continue to face downward momentum amid a series of consecutive losses.

Read full news article

Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-03 13:45:24

Prism Medico & Pharmacy Ltd has encountered significant selling pressure, with the stock registering a sharp decline and exhibiting a complete absence of buyers on the trading day. This distress selling signals heightened market caution surrounding the company’s near-term prospects.

Read full news article

Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-01 09:50:25

Prism Medico & Pharmacy Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.96% today and exhibiting no buying interest. This distress selling comes amid a series of consecutive losses, signalling heightened investor caution in the Non Banking Financial Company (NBFC) sector.

Read full news article

Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-25 09:40:58

Prism Medico & Pharmacy Ltd is currently experiencing significant selling pressure, with the stock registering only sell orders and no buyers in the queue. This distress selling has resulted in a continuation of losses, reflecting a challenging phase for the company within the Non Banking Financial Company (NBFC) sector.

Read full news article

Prism Medico & Pharmacy Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-24 11:30:41

Prism Medico & Pharmacy Ltd is experiencing severe selling pressure, with the stock registering a lower circuit and an absence of buyers on the trading day. The company’s shares have recorded consecutive losses across multiple time frames, signalling distress selling and a challenging market environment for this Non Banking Financial Company (NBFC).

Read full news article

Is Prism Medico overvalued or undervalued?

2025-11-19 08:08:21

As of 18 November 2025, the valuation grade for Prism Medico has moved from very attractive to fair. Based on the current analysis, the company appears to be fairly valued. The key ratios include a PE ratio of 19.52, an EV to EBITDA of 11.84, and a Price to Book Value of 0.79. In comparison to its peers, Prism Medico's valuation is significantly lower than that of Max Healthcare, which has a PE ratio of 77.03, and Apollo Hospitals, with a PE ratio of 63.51. Despite the fair valuation, Prism Medico has underperformed the Sensex over the past year, with a stock return of -24.32% compared to the Sensex's return of 9.48%....

Read full news article

View All News